ERIC A. ADAMS - 27 May 2024 Form 4 Insider Report for InMed Pharmaceuticals Inc. (INM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INM	Employee Stock Option (Expiration)	Expiration (or cancellation) of long derivative position with value received	$0	-1,139	-0.7%	$0.000000	161,000	27 May 2024	Common shares	1,139	$263.18	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Converted from the Canadian dollar exercise price of C$358.875 using an exchange rate of C$1.3636 (as of May 27th, 2024) = $US1.00